Affordable Access

Publisher Website

Antiphospholipid antibodies and stroke

Authors
Journal
Seminars in Cerebrovascular Diseases and Stroke
1528-9931
Publisher
Duke University Press
Publication Date
Volume
2
Issue
2
Identifiers
DOI: 10.1053/scds.2002.124067
Keywords
  • Antiphospholipid Antibody
  • Antiphospholipid Antibody Syndrome
  • Systemic Lupus Erythematosus
  • Cerebral Vascular Ischemia
  • Cerebral Venous Thrombosis
  • Thromboembolism
Disciplines
  • Medicine

Abstract

Abstract Antiphospholipid antibodies (aPLs) have been associated with recurrent thromboembolic events, thrombocytopenia, and cardiac valvular disease. Although these antibodies were originally described as a complication of systemic lupus erythematosus (SLE) and other connective tissue diseases, it is now recognized that aPLs can develop in the absence of other autoimmune disorders. Cross-sectional and prospective studies have suggested that aPLs are an independent risk factor for stroke, particularly when cerebral ischemia develops in young persons or in the setting of SLE. We will examine the present state of research on aPLs as a risk factor for thrombotic and embolic stroke and cerebral venous thrombosis. We will also review the current state of management strategies for patients with the antiphospholipid antibodies and stroke.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Antiphospholipid antibodies and stroke.

on Current cardiology reports March 2004

Stroke and antiphospholipid antibodies in children...

on Archives of Medical Research 1997

Antiphospholipid antibodies and ischemic stroke.

on Heart disease and stroke : a j... 1992

Antiphospholipid antibodies and stroke in young wo...

on Stroke; a journal of cerebral... October 2002
More articles like this..